From decoding the human genome to exploring the universe, science has made huge strides in the 21st century.

Parag and Andreas share their reflection on proteomics in 2025.

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Find our takeaways from HUPO 2025 and learn why we're excited work with members of the HUPO community to redefine proteomics!

Scribe Therapeutics CEO on how CRISPR technologies are ready to move beyond rare diseases and take on the world’s biggest killers.

Yaghi created a field called reticular chemistry, which involves stitching together molecular building blocks to form porous structures — metal-organic frameworks (MOFs) — with myriad applications.

Gene editing and epigenetic silencing offer two ways of changing the basic biology of cholesterol for future treatments beyond statins.

Podcast Episode · ON CRISPR: The Story of Jennifer Doudna with Walter Isaacson · S3 E1 · 26m

A network of ultrawealthy investors including Peter Thiel and Sam Altman are infusing the longevity industry with cash and making big bets on where the science is headed.

OpenAI and Retro Biosciences report AI-made proteins showed 50x better cell reprogramming using modified Yamanaka factors, with potential therapeutic applications

Formation Bio licenses first-in-class anti-CD226 antibody from IMIDomics for IBD treatment, marking first drug acquisition since $372M Series D raise in 2023.

A planned addition to the campus's Innovation Zone will expand lab space for the Innovative Genomics Institute and build out the largest innovation hub — Bakar Labs — at any U.S. university.

Learn how Iterative Mapping of proteoforms can provide novel insights into biology with tau proteoforms as exemplars.

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead immuno-oncology combination, BOT/BAL.

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology

The tech bros believe we are close to conquering death. Matt Rudd travels to the ‘superhuman summit’ in Stockholm to sample body scanners and bone broth

A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.

Genesis Therapeutics appoints Aleksandra Faust as Chief Artificial Intelligence Officer

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically...

A new supercomputer named after a winner of the Nobel Prize in chemistry will help power artificial intelligence technology and scientific discoveries from a perch in the hills above the University of...

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as...

Seven habits of highly intelligent people

A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with the Murdoch Children's Research Institute in Australia. The California bio...

A Bay Area executive-level conference advancing human health through the convergence of life science and technology.

Powerful AI-based tools have begun to accelerate disease diagnoses and mine data in search of novel drugs

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to address the longtime challenge of bringing their treatments to patients by sharpe...